In STEM4youth (2016-2018), they contributed hands-on learning activities, citizen science experiments, and interactive science storytelling aimed at young audiences across Europe.
FONDAZIONE UMBERTO VERONESI ETS
Italian cancer foundation providing public credibility, science communication, and STEM education expertise to biomedical and research consortia.
Their core work
Fondazione Umberto Veronesi is a Milan-based Italian non-profit foundation named after the late oncologist Umberto Veronesi, dedicated to funding cancer research, supporting young biomedical scientists, and building public trust in science. In H2020, they contributed as a STEM education partner in STEM4youth — bringing hands-on, experiment-driven learning and citizen science approaches to European youth — and as a third-party collaborator in TRANSMIT, a cancer biology network studying the role of mitochondria in tumour development. Their distinctive contribution to research consortia lies at the intersection of scientific credibility and public communication: they translate complex biomedical research into formats accessible to general audiences, educators, and potential patients.
What they specialise in
As a third-party partner in TRANSMIT (2017-2021), an MSCA training network on mitochondria in tumorigenesis, they supported dissemination or public engagement for cancer biology research.
STEM4youth keywords include citizen science experiments and enquiry-based learning, indicating structured methods for involving non-specialists in scientific processes.
How they've shifted over time
Their two H2020 projects ran concurrently (2016–2021) rather than sequentially, making a clear chronological evolution difficult to establish. Their early keyword footprint — learning by experiment, citizen science, enquiry-based learning, hands-on activities — is entirely centred on science education methodology, reflecting an active participation role in STEM4youth. In TRANSMIT, they held a third-party (unfunded) position with no associated keywords, suggesting a lighter, dissemination-focused contribution rather than a research-active one. The overall signal is of an organisation that engages EU research consortia primarily as a science communication and public legitimacy asset, not as a technical research contributor.
With no coordinator roles and a shift toward third-party participation, the foundation appears to be positioning itself as a trusted public-facing partner for biomedical research consortia rather than expanding its own research activity.
How they like to work
Fondazione Umberto Veronesi has never led an H2020 project, consistently joining as a participant or third-party partner. Despite only two projects, they accumulated 22 distinct consortium partners across 12 countries, indicating that they join large, multi-national consortia — a pattern typical of organisations that provide communication, engagement, or patient-advocacy value to research networks. Their role is not to run experiments or deliver technical outputs, but to lend credibility, reach, and public-facing capacity to consortia that need a trusted non-academic voice.
Despite only two projects, the foundation engaged 22 unique partners across 12 countries — a sign they operate within large, geographically diverse consortia. Their network spans both education-focused and biomedical research communities, reflecting the dual nature of the foundation's mission.
What sets them apart
Fondazione Umberto Veronesi carries the brand equity of one of Italy's most recognised oncologists, giving it unusual public trust and media reach for an NGO in EU research consortia. This makes them particularly valuable for projects that need genuine public credibility in cancer science or science-for-society narratives — not just a token dissemination partner. Consortia building in oncology, biomedical training, or science education targeting Italian or broader European publics would find in them a partner with established donor networks, patient community ties, and a proven track record of science communication at scale.
Highlights from their portfolio
- STEM4youthTheir only directly funded H2020 project (EUR 216,311), where they were an active participant contributing citizen science and hands-on learning frameworks to a multi-country STEM promotion initiative.
- TRANSMITParticipation as a third-party partner in an MSCA training network on mitochondria in cancer — directly aligned with the foundation's core oncology mission, though without direct EC funding.